169 related articles for article (PubMed ID: 28415882)
1. RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.
Siddhartha VT; Pindiprolu SKSS; Chintamaneni PK; Tummala S; Nandha Kumar S
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):387-397. PubMed ID: 28415882
[TBL] [Abstract][Full Text] [Related]
2. Application of quality-by-design approach to optimize diallyl disulfide-loaded solid lipid nanoparticles.
Talluri SV; Kuppusamy G; Karri VV; Yamjala K; Wadhwani A; Madhunapantula SV; Pindiprolu SS
Artif Cells Nanomed Biotechnol; 2017 May; 45(3):474-488. PubMed ID: 27112220
[TBL] [Abstract][Full Text] [Related]
3. Diallyl disulfide inhibits growth and metastatic potential of human triple-negative breast cancer cells through inactivation of the β-catenin signaling pathway.
Huang J; Yang B; Xiang T; Peng W; Qiu Z; Wan J; Zhang L; Li H; Li H; Ren G
Mol Nutr Food Res; 2015 Jun; 59(6):1063-75. PubMed ID: 25755089
[TBL] [Abstract][Full Text] [Related]
4. Effect of diallyl disulfide on insulin-like growth factor signaling molecules involved in cell survival and proliferation of human prostate cancer cells in vitro and in silico approach through docking analysis.
Arunkumar R; Sharmila G; Elumalai P; Senthilkumar K; Banudevi S; Gunadharini DN; Benson CS; Daisy P; Arunakaran J
Phytomedicine; 2012 Jul; 19(10):912-23. PubMed ID: 22739413
[TBL] [Abstract][Full Text] [Related]
5. Diallyl disulfide causes caspase-dependent apoptosis in human cancer cells through a Bax-triggered mitochondrial pathway.
Nagaraj NS; Anilakumar KR; Singh OV
J Nutr Biochem; 2010 May; 21(5):405-12. PubMed ID: 19423321
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of natural and synthetic diallyl disulfide on apoptosis of human breast-cancer MCF-7 cells.
Jun Z; Suzuki M; Xiao J; Wen J; Talbot SG; Li GC; Xu M
Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):113-9. PubMed ID: 18289126
[TBL] [Abstract][Full Text] [Related]
7. Diallyl disulfide induces apoptosis in human colon cancer cell line (COLO 205) through the induction of reactive oxygen species, endoplasmic reticulum stress, caspases casade and mitochondrial-dependent pathways.
Yang JS; Chen GW; Hsia TC; Ho HC; Ho CC; Lin MW; Lin SS; Yeh RD; Ip SW; Lu HF; Chung JG
Food Chem Toxicol; 2009 Jan; 47(1):171-9. PubMed ID: 19038304
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibitory effects of diallyl disulfide on human breast cancer cell lines.
Nakagawa H; Tsuta K; Kiuchi K; Senzaki H; Tanaka K; Hioki K; Tsubura A
Carcinogenesis; 2001 Jun; 22(6):891-7. PubMed ID: 11375895
[TBL] [Abstract][Full Text] [Related]
9. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
10. [Effects of diallyl disulfide on differential expression of apoptosis-associated genes in leukemia cell line HL-60].
Lin M; Xie HL; Su Q; Zhou JG; Tan H; Yi L; Tang HL; Huang Y; Shi Y
Ai Zheng; 2007 Apr; 26(4):351-6. PubMed ID: 17430650
[TBL] [Abstract][Full Text] [Related]
11. Effect of diallyl disulfide on Ca2+ movement and viability in PC3 human prostate cancer cells.
Chen WC; Hsu SS; Chou CT; Kuo CC; Huang JK; Fang YC; Chang HT; Tsai JY; Liao WC; Wang BW; Shieh P; Kuo DH; Jan CR
Toxicol In Vitro; 2011 Apr; 25(3):636-43. PubMed ID: 21232596
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
13. Novel synthetic analogs of diallyl disulfide triggers cell cycle arrest and apoptosis via ROS generation in MIA PaCa-2 cells.
Saini V; Manral A; Arora R; Meena P; Gusain S; Saluja D; Tiwari M
Pharmacol Rep; 2017 Aug; 69(4):813-821. PubMed ID: 28591670
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis and histone hyperacetylation by diallyl disulfide in prostate cancer cell line PC-3.
Arunkumar A; Vijayababu MR; Gunadharini N; Krishnamoorthy G; Arunakaran J
Cancer Lett; 2007 Jun; 251(1):59-67. PubMed ID: 17150304
[TBL] [Abstract][Full Text] [Related]
15. Diallyl disulfide selectively causes checkpoint kinase-1 mediated G2/M arrest in human MGC803 gastric cancer cell line.
Ling H; Lu LF; He J; Xiao GH; Jiang H; Su Q
Oncol Rep; 2014 Nov; 32(5):2274-82. PubMed ID: 25176258
[TBL] [Abstract][Full Text] [Related]
16. The role of reactive oxygen species (ROS) production on diallyl disulfide (DADS) induced apoptosis and cell cycle arrest in human A549 lung carcinoma cells.
Wu XJ; Kassie F; Mersch-Sundermann V
Mutat Res; 2005 Nov; 579(1-2):115-24. PubMed ID: 16024053
[TBL] [Abstract][Full Text] [Related]
17. Effects of diallyl disulfide (DADS) on expression of apoptosis associated proteins in androgen independent human prostate cancer cells (PC-3).
Gayathri R; Gunadharini DN; Arunkumar A; Senthilkumar K; Krishnamoorthy G; Banudevi S; Vignesh RC; Arunakaran J
Mol Cell Biochem; 2009 Jan; 320(1-2):197-203. PubMed ID: 18759062
[TBL] [Abstract][Full Text] [Related]
18. Diallyl disulfide (DADS) boosts TRAIL-Mediated apoptosis in colorectal cancer cells by inhibiting Bcl-2.
Kim HJ; Kang S; Kim DY; You S; Park D; Oh SC; Lee DH
Food Chem Toxicol; 2019 Mar; 125():354-360. PubMed ID: 30677442
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species-dependent c-Jun NH2-terminal kinase/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide.
Filomeni G; Aquilano K; Rotilio G; Ciriolo MR
Cancer Res; 2003 Sep; 63(18):5940-9. PubMed ID: 14522920
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of diallyl disulfide on neuronal cells depend on its concentration.
Kim JG; Koh SH; Lee YJ; Lee KY; Kim Y; Kim S; Lee MK; Kim SH
Toxicology; 2005 Jul; 211(1-2):86-96. PubMed ID: 15863251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
